238. Vitamin D-resistant rickets Clinical trials / Disease details

Clinical trials : 28 / Drugs : 20 - (DrugBank : 9) / Drug target genes : 3 - Drug target pathways : 16

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01748812 (ClinicalTrials.gov)	November 16, 2012	11/12/2012	Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)	Open-label Dose-titration Study of the Tolerability and Efficacy of Cinacalcet to Treat Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia	Osteomalacia	Drug: Osteomalacia	National Institute of Dental and Craniofacial Research (NIDCR)	NULL	Terminated	18 Years	70 Years	All	1	Phase 1	United States
2	NCT00844740 (ClinicalTrials.gov)	February 2009	12/2/2009	Calcimimetics in Hypophosphatemic Rickets	Effect of Cinacalcet on the Long-Term Treatment of Familial Hypophosphatemic Rickets	Familial Hypophosphatemic Rickets	Drug: Cinacalcet	Children's Mercy Hospital Kansas City	NULL	Enrolling by invitation	5 Years	21 Years	Both	10	N/A	United States
3	NCT00195936 (ClinicalTrials.gov)	June 2005	13/9/2005	Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic Rickets	Effect of Calcimimetic (Cinacalcet) on Phosphate-Induced Hyperparathyroidism in Children With Hypophosphatemic Rickets	Hypophosphatemic Rickets, X-Linked Dominant	Drug: Cinacalcet	Children's Mercy Hospital Kansas City	NULL	Completed	5 Years	N/A	All	8	Phase 1	United States